Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Tang Y, Liu W, Kadu S, Johnson O, Hasanali ZS, Kelly A, Shestov A, Pajarillo R, Greenblatt E, Holmes M, Wang LP, Shih N, O'Connor RS, Ruella M, Garfall AL, Allman D, Vogl DT, Cohen A, June CH, Sheppard NC.
Tang Y, et al. Among authors: kelly a.
Blood. 2024 Jan 11;143(2):139-151. doi: 10.1182/blood.2022018658.
Blood. 2024.
PMID: 37616575
Free PMC article.